On January 12, 2009, AB Invalda completed a transaction whereby it sold part of its shares in AB Sanitas.<\/p>\n
Invalda had announced earlier that on October 24, 2008, the company signed legal documentation regarding the sale of 6 314 502 shares, i.e. 20.3 % of the share capital, of AB Sanitas for a total price of EUR30 mln to Baltic Pharma Limited, an investment vehicle for funds managed by Citi Venture Capital International (CVCI).<\/p>\n
The transaction was implemented in two stages: (a) 1 555 296 Sanitas shares, 5% of share capital, were transferred for LTL 25.51 mln on October 28, 2008. (b) Upon fulfillment of all necessary conditions precedent on January 12, 2009, the balance of 4 759 206 shares (15.3%) were transferred for LTL 78.01 mln.<\/p>\n
As per the terms of the agreement with Baltic Pharma Limited, the price paid for the shares and the number of shares transferred, may be adjusted upon a future sale of the shares by Baltic Pharma Limited, depending on the price received by the latter from such sale. <\/p>\n
Following this transaction, AB Invalda owns 25% of AB Sanitas\u2019 votes and intends to retain this interest over the medium term.<\/p>\n
Darius Sulnis
President
+370 5 273 48 76<\/p>\n","protected":false},"excerpt":{"rendered":"
On January 12, 2009, AB Invalda completed a transaction whereby it sold part of its shares in AB Sanitas. Invalda had announced earlier that on October 24, 2008, the company..<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[15],"tags":[6],"class_list":["post-13603","post","type-post","status-publish","format-standard","hentry","category-regulated-information","tag-imported"],"acf":[],"yoast_head":"\n